uBIOSEP

About the project:

The μBIOSEP represents an applied research project solved by a Czech-Norwegian consortium consisting of research institutions with expertise in analytical chemistry, microfluidics, and microsystems fabrication, and a business partner operating in the related disciplines.

2021

After forming the research teams, development efforts started on the project’s primary goal of introducing miniaturized systems for highly efficient and sensitive analyses of challenging but scientifically or clinically significant biological samples, such as human plasma. In addition, the consortium also fulfilled administrative tasks primarily supporting the achievement of the scientific goals, the outreach of the project, and the dissemination of results obtained.

2022

In the second year of the uBIOSEP project, miniaturized interfaces for electrospray ionization and a microfluidic device enabling their coupling with commercial mass spectrometers were fabricated. After the development is complete, the resulting system will be suitable for highly sensitive and efficient analyses of biologically or clinically significant biological samples. Furthermore, the concept of miniaturized valves was investigated using computer simulations. The microvalves represent a key component of the envisaged system for the separation of short fragments of the circulating DNA that can be used for cancer diagnosis from blood plasma samples using the so-called liquid biopsy technique.

Beneficiary and project partners:

Ústav analytické chemie AV ČR, v. v. i.
SINTEF AS
WATREX Praha, s.r.o.

The μBIOSEP project benefits from a € 1.2 mil grant from Iceland, Liechtenstein and Norway through the EEA Grants and Technology Agency of the Czech Republic.
The project is carried out under the KAPPA funding programme for applied research, experimental development and innovation, managed by the Technology Agency of the Czech Republic.